The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 26.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (9 analysts) rates it buy, with a mean price target of $295.
Franco-Nevada Corp
FNV · the NYSE · USD · Market cap $51.3B
Franco-Nevada Corporation operates as a royalty and stream company focused on precious metals in South America, Central America, Mexico, the United States, Canada, Australia, Europe, and Africa.
Not yet scoredAt the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Franco-Nevada Corp holds its Markup at $266.00. The statistical read favours the buyers, held for 16 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 16 days |
| Price at the screen | $266.00 |
| Valuation | 34.82 trailing · 28.39 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.96 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 13.41% | Below 33% | Cash held in interest-bearing accounts and securities is 13.4% of assets, under the one-third limit. | Pass |
| Receivables | 11.08% | Below 49% | Money owed to the company is 11.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.55% | Below 5% | Only 1.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 32.5% above the base estimate.
Third-party analyst targets: 9 covering, consensus None. The average target sits +5% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGold royalties ride volatile price swings
Picture a firm that takes a cut from gold output across dozens of mines without footing the exploration bill. Franco-Nevada collects those royalties from the Americas to Africa and posts strong margins when metal prices rise.
Yet the shares sit above our fair value with a forward multiple that already bakes in continued strength. Revenue has surged but this remains a cyclical business where peak earnings often mask the risk that multiples compress once prices normalise.
A narrow moat and commodity swings leave little margin for error, especially when analyst targets assume the good times last. Ethical checks pass but the cycle itself signals caution rather than opportunity. Analysis, not advice.
| Forward P/E | 28.4xcheap for a company growing this fast |
| Trailing P/E | 34.8xa premium valuation |
| EPS, trailing | 7.64 |
| EPS, forward | 9.37 |
| Revenue growth | +58.2%growing very fast |
| Profit margin | 64.2%highly profitable on every dollar of sales |
| Return on equity | 19.9%a solid return on shareholder capital |
| FCF yield | 0.92% |
| Dividend yield | 84.00% |
| Current ratio | 9.38comfortably covers its short-term bills |
| Beta | 0.96steadier than the market |
| 52-week range | 181.50 - 285.67 |
| Moat | NARROW |
| Market cap | $51.3B |
The risks · The things to watch: its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFNV trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (9 analysts) rates it buy, with a mean price target of $295.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (9 analysts) rates it buy, with a mean price target of $295.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Gold Just Had Its Worst Quarter in 13 Years, and GDX Might Be the Contrarian Rebound Nobody’s Talking About 24/7 Wall St. · 6 Jul 2026
- Worried Gold Is Overcrowded? 3 Stocks for Retirees to Consider Instead, Ranked 24/7 Wall St. · 3 Jul 2026
- Franco-Nevada (FNV) Upgraded to Buy: Here's Why Zacks · 18 Jun 2026
- Wall Street Analysts Predict a 30.99% Upside in Franco-Nevada (FNV): Here's What You Should Know Zacks · 18 Jun 2026
- Is Record Q1 2026 Results And New Chair Altering The Investment Case For Franco-Nevada (TSX:FNV)? Simply Wall St. · 13 Jun 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $237.60 | -12.1% | · | $879 | -12.1% |
| 2 months | $261.55 | -20.2% | · | $799 | -20.2% |
| 3 months | $263.50 | -20.7% | $0.44 | $794 | -20.6% |
| 6 months | $213.86 | -2.4% | $0.44 | $979 | -2.1% |
| 1 year | $163.99 | +27.4% | $0.82 | $1,279 | +27.9% |
| 2 years | $118.19 | +76.7% | $2.28 | $1,786 | +78.6% |
| 3 years | $141.98 | +47.1% | $3.66 | $1,497 | +49.7% |
| 5 years | $145.02 | +44.0% | $5.88 | $1,481 | +48.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FNV does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.